Revolution Medicines, Inc. (RVMD) Analyst Forecast

$46.71

north_east
$1.01 (2.21%)
Day's range
$45.72
Day's range
$47.59

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/03/2025 RBC Capital Leonid Timashev $77.00 $58.84   30.86%
10/17/2025 National Bank Alex Stranahan $80.00 $53.81   48.67%
08/19/2025 Piper Sandler Kelsey Goodwin $75.00 $36.56   105.14%
05/14/2025 H.C. Wainwright Robert Burns $72.00 $41.88   71.92%
04/01/2025 Stifel Nicolaus Benjamin Burnett $64.00 $33.62   90.36%
01/08/2025 UBS Eliana Merle $71.00 $44.33   60.16%
11/07/2024 Piper Sandler Joseph Catanzaro $70.00 $56.09   24.8%
11/04/2024 H.C. Wainwright Raghuram Selvaraju $62.00 $55.87   10.97%
10/28/2024 Guggenheim Michael Schmidt $82.00 $46.96   74.62%
10/28/2024 Oppenheimer Jay Olson $60.00 $46.83   28.12%
10/15/2024 Oppenheimer Jay Olson $55.00 $49.22   11.74%
09/17/2024 Piper Sandler Joseph Catanzaro $57.00 $44.24   28.84%
08/08/2024 Needham Ami Fadia $61.00 $42.73   42.76%
07/15/2024 Wedbush Robert Driscoll $59.00 $47.01   25.52%
04/19/2024 Stifel Nicolaus Ben Burnett $43.00 $35.83   20.01%
04/12/2024 Needham Ami Fadia $46.00 $37.41   22.96%
04/12/2024 Oppenheimer Jay Olson $45.00 $37.41   20.29%
04/09/2024 Raymond James Laura Prendergast $48.00 $32.99   45.5%
11/16/2023 Raymond James Dane Leone $30.00 $21.25   41.18%

Revolution Medicines, Inc. FAQ's

Revolution Medicines, Inc. has been rated by research analysts at RBC Capital, National Bank, Raymond James, Stifel Nicolaus, Truist Financial, Piper Sandler in the past 90 days.